Cost-effectiveness of two types of dysphagia care in head and neck cancer: a preliminary report.
Ear Nose Throat J
; 80(8): 553-6, 558, 2001 Aug.
Article
em En
| MEDLINE
| ID: mdl-11523474
ABSTRACT
We conducted a prospective, preliminary study to compare the cost-effectiveness of two different instrument-based techniques for diagnosing and managing dysphagia in 30 consecutive hospitalized patients with head and neck cancer. The two techniques are videofluoroscopy via modified barium swallow (MBS) and videoendoscopy via flexible endoscopic evaluation of swallowing with sensory testing (FEESST). Medicare was the primary insurer of all patients. Fifteen of these patients had their dysphagia diagnosed and managed by MBS and the other 15 by FEESST. Cost-effectiveness was assessed by determining the average Medicare reimbursement for each procedure. We found that the mean reimbursements were $451.01 (+/- $50.55) for MBS and $321.23 (+/- $3.01) for FEESST. The mean reimbursement for FEESST was significantly lower than that for MBS (p < 0.0001; Mann-Whitney U test). We conclude that FEESST appears to be more cost-effective than MBS for the inpatient management of dysphagia in patients with head and neck cancer.
Buscar no Google
Coleções:
01-internacional
Contexto em Saúde:
1_ASSA2030
Base de dados:
MEDLINE
Assunto principal:
Transtornos de Deglutição
/
Neoplasias de Cabeça e Pescoço
/
Serviços de Saúde
Tipo de estudo:
Health_economic_evaluation
Aspecto:
Determinantes_sociais_saude
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ear Nose Throat J
Ano de publicação:
2001
Tipo de documento:
Article